HELIOS TECHNOLOGIES DRIVER
HELIOS TECHNOLOGIES PORTABLE

The PoNS device is indicated for use in the United States as a short-term treatment of gait deficit due to mild-to-moderate symptoms from multiple sclerosis (“MS”) and is to be used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only.

This payout ratio is at a healthy, sustainable level, below 75. The dividend payout ratio of Helios Technologies is 10.47. Helios Technologies does not have a long track record of dividend growth.

HELIOS TECHNOLOGIES PORTABLE

The Portable Neuromodulation Stimulator (PoNS) is an innovative non-surgical medical device, inclusive of a controller and mouthpiece, which delivers electrical stimulation to the surface of the tongue to improve balance and gait. Helios Technologies has a dividend yield of 0.71, which is in the bottom 25 of all stocks that pay dividends.

HELIOS TECHNOLOGIES DRIVER

Helios focuses on acquiring and/or building high potential platform companies in core economic sectors, with an emphasis on portfolio operations as a driver of value. For more information, visit About the PoNS Device and PoNS Therapy Helios Technologies Company Stats Industry Capital Goods Founded 1970 Headquarters Sarasota Country United States CEO Josef Matosevic Employees 2,000 Forbes Lists 39 Best Mid-Cap Companies (2022). Helios Private Equity follows a highly flexible first principles investment approach, applying developed world investment tools in Africa. The Company’s first commercial product is the Portable Neuromodulation Stimulator (PoNS®).

Helios sells its products to customers in over 85 countries around. Helios is an Israeli company founded in 2018, supported by the Israel Space Agency at the Ministry of Innovation, Science and Technology, Ministry of Energy and the Innovation Authority. The novel format pushes LED light source performance to a new level, and marks a new era in terms of very high. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. Helios Technologies is a global leader in highly engineered motion control and electronic controls technology for diverse end markets, including construction, material handling, agriculture, energy, recreational vehicles, marine, health and wellness. Sylvania introduced the concept of our Helios LED filament technology, in which the special gas-cooled design enables uniform 360° light distribution, superb thermal performance, and long lifetime with excellent lumen maintenance.

Helios technologies